Back to GetFilings.com



Table of Contents

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

Form 10-Q

 

(Mark one)

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 2004

 

OR

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to             

 

Commission File Number 0-28672

 


 

Optika Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   95-4154552

(State or other jurisdiction of

incorporation or organization)

  (I.R.S. Employer Identification No.)

7450 Campus Drive, 2nd Floor

Colorado Springs, CO

  80920
(Address of principal executive offices)   (Zip Code)

 

(719) 548-9800

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2). Yes ¨  No x

 

9,444,493 shares of the Registrant’s Common Stock, $.001 par value per share, were outstanding as of May 7, 2004

 



Table of Contents

INDEX

 

               PAGE
           

PART 1—FINANCIAL INFORMATION

    
     Item 1 – Condensed Consolidated Financial Statements     
          Condensed Consolidated Balance Sheets as of March 31, 2004 and
December 31, 2003 (Unaudited)
   1
          Condensed Consolidated Statements of Operations for the three-month
periods ended March 31, 2004 and 2003 (Unaudited)
   2
          Condensed Consolidated Statements of Cash Flows for the three-month
periods ended March 31, 2004 and 2003 (Unaudited)
   3
          Notes to Condensed Consolidated Financial Statements (Unaudited)    4
     Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations    7
     Item 3 – Quantitative and Qualitative Disclosures About Market Risk    21
     Item 4 – Controls and Procedures    21

PART II—OTHER INFORMATION

    
     Item 6 – Exhibits and Reports on Form 8-K    22
     Signatures         23


Table of Contents

OPTIKA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

 

     March 31,
2004


    December 31,
2003


 
     (unaudited)        

Assets

                

Current assets:

                

Cash and cash equivalents

   $ 4,283     $ 3,929  

Restricted cash and cash equivalents

     100       100  

Short-term investments

     5,153       5,153  

Accounts receivable, net

     4,475       4,696  

Other current assets

     462       523  
    


 


Total current assets

     14,473       14,401  
    


 


Property and equipment, net

     678       683  

Intangible assets, net

     559       584  

Goodwill

     1,166       1,166  

Other assets

     126       221  
    


 


     $ 17,002     $ 17,055  
    


 


Liabilities and Stockholders’ Equity

                

Current liabilities:

                

Accounts payable

   $ 730     $ 510  

Accrued expenses

     592       1,145  

Accrued compensation expense

     966       1,108  

Deferred revenue

     6,703       6,358  
    


 


Total current liabilities

     8,991       9,121  
    


 


Stockholders’ equity:

                

Common stock; $.001 par value; 25,000,000 shares authorized; 9,436,993 and 9,327,061 shares issued and outstanding at March 31, 2004 and December 31, 2003, respectively

     9       9  

Series A-1 preferred stock; $.001 par value; 731,851 shares authorized, issued and outstanding

     5,199       5,199  

Additional paid-in capital

     30,647       30,491  

Accumulated deficit

     (27,844 )     (27,765 )
    


 


Total stockholders’ equity

     8,011       7,934  
    


 


     $ 17,002     $ 17,055  
    


 


 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1


Table of Contents

OPTIKA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except per share amounts)

 

     Three Months Ended March 31,

 
     2004

    2003

 

Revenues:

                

Licenses

   $ 1,873     $ 1,231  

Maintenance and other

     3,749       3,115  
    


 


Total revenues

     5,622       4,346  
    


 


Cost of revenues:

                

Licenses

     170       180  

Maintenance and other

     1,047       925  
    


 


Total cost of revenues

     1,217       1,105  
    


 


Gross profit

     4,405       3,241  
    


 


Operating expenses:

                

Sales and marketing

     2,384       2,227  

Research and development

     1,164       1,191  

General and administrative

     570       399  

Merger related expenses

     417       —    
    


 


Total operating expenses

     4,535       3,817  
    


 


Loss from operations

     (130 )     (576 )

Other income, net

     51       18  
    


 


Loss before income tax provision

     (79 )     (558 )

Income tax provision

     —         —    
    


 


Net loss

   $ (79 )   $ (558 )
    


 


Basic and diluted net loss per common share

   $ (0.01 )   $ (0.07 )
    


 


Basic and diluted weighted average number of common shares outstanding

     9,370       8,351  
    


 


 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2


Table of Contents

OPTIKA INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

     Three Months Ended March 31,

 
     2004

    2003

 

Cash Flows From Operating Activities:

                

Net loss

   $ (79 )   $ (558 )

Adjustments to reconcile net loss to net cash provided by operating activities:

                

Depreciation and amortization

     112       131  

Changes in assets and liabilities:

                

Accounts receivable, net

     221       733  

Other assets

     156       (21 )

Accounts payable

     220       71  

Accrued expenses and accrued compensation expense

     (695 )     (312 )

Deferred revenue

     345       40  
    


 


Net cash provided by operating activities.

     280       84  
    


 


Cash Flows From Investing Activities:

                

Capital expenditures

     (82 )     (54 )
            


Net cash used by investing activities

     (82 )     (54 )
    


 


Cash Flows From Financing Activities:

                

Proceeds from issuance of common stock

     156       33  
    


 


Net cash provided by financing activities

     156       33  
    


 


Net increase in cash and cash equivalents

     354       63  

Cash and cash equivalents at beginning of period

     3,929       2,458  
    


 


Cash and cash equivalents at end of period

   $ 4,283     $ 2,521  
    


 


 

 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3


Table of Contents

OPTIKA INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

1. Basis of Presentations

 

The unaudited condensed consolidated financial statements included herein reflect all adjustments, consisting only of normal recurring adjustments, which in the opinion of management are necessary to fairly present our consolidated financial position, results of operations, and cash flows for the periods presented. Certain information and footnote disclosures normally included in audited financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to the Securities and Exchange Commission’s (SEC’s) rules and regulations. The consolidated results of operations for the period ended March 31, 2004 is not necessarily indicative of the results to be expected for any subsequent quarter or for the entire fiscal year ending December 31, 2004. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended December 31, 2003, included in the Annual Report on Form 10-K for the year ended December 31, 2003, as amended, of Optika Inc. (the “Company”).

 

2. Recent Developments

 

On January 12, 2004, we announced that we had entered into a definitive agreement to merge with Stellent, Inc. Under the terms of the merger agreement, each share of Optika common stock would be converted into .44 shares of Stellent common stock (subject to adjustment in certain circumstances as described below) and the holders of our preferred stock would receive $10 million in cash. If, based on the average closing price of Stellent’s common stock over a ten day period immediately prior to the closing of the merger, the .44 to one exchange ratio would result in our common stockholders receiving in excess of $4.00 per share of Stellent common stock, the exchange ratio will be adjusted so that 20% of the aggregate merger consideration in excess of $4.00 per share would be allocated to the holders of our preferred stock and 80% of the aggregate merger consideration in excess of $4.00 per share would be allocated to the holders of the common stock. The merger will be accounted for as a purchase transaction by Stellent and is expected to be completed late in the second calendar quarter of 2004. The closing is subject to regulatory approval, Optika and Stellent stockholder approval and customary closing conditions. In connection with the proposed merger, Stellent and Optika have filed a joint proxy statement/prospectus with the Securities and Exchange Commission. Investors and security holders of Stellent and Optika are urged to read the joint proxy statement/prospectus and other relevant materials as they become available because they will contain important information about Stellent, Optika and the proposed merger. Investors and security holders may obtain without charge copies of the joint proxy statement/prospectus and other relevant materials, and any other documents filed by Stellent or Optika with the Securities and Exchange Commission at the SEC’s web site at http://www.sec.gov. A free copy of the joint proxy statement/prospectus and other relevant materials, and any other documents filed by Stellent or Optika with the SEC, may also be obtained from Stellent and Optika. In addition, investors and security holders may access copies of the documents filed with the SEC by Stellent on Stellent’s website at www.Stellent.com. Investors and security holders may obtain copies of the documents filed with the SEC by Optika on Optika’s website at www.Optika.com.

 

3. Net Loss Per Common Share and Stock Based Compensation

 

Net Loss Per Common Share

 

Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the period. Diluted loss per share is computed using the weighted average number of common shares outstanding plus all dilutive potential common shares outstanding. During the first three months of 2004, 50,000 options to purchase our common stock were granted. During the first three months of 2003, 177,500 options to purchase our common stock were granted.

 

4


Table of Contents

The following is the reconciliation of the numerators and denominators of the basic and diluted loss per share computations (in thousands, except per share data):

 

     Three Months Ended
March 31,


 
     2004

    2003

 

Basic Loss Per Share

                

Net loss

   $ (79 )   $ (558 )

Basic weighted average common shares outstanding

     9,370       8,351  

Basic net loss per common share

   $ (0.01 )   $ (0.07 )

Effect of Dilutive Securities:

                

Options and warrants

     —         —    

Diluted weighted average common shares outstanding

     9,370       8,351  

Diluted net loss per common share

   $ (0.01 )   $ (0.07 )

 

In the first quarter of 2004 and 2003, 2,808,004 and 3,192,347, respectively, options and warrants were excluded from the dilutive stock calculation because of their antidilutive effect on net loss per share.

 

Stock-Based Compensation

 

We apply the intrinsic value-based method of accounting prescribed by Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations including FASB Interpretation No. 44, “Accounting for Certain Transactions involving Stock Compensation, an interpretation of APB Opinion No. 25,” to account for our fixed plan stock options. Under this method, compensation expense is recorded on the date of grant only if the current market price of the underlying stock exceeds the exercise price. SFAS No. 123, “Accounting for Stock-Based Compensation,” establishes accounting and disclosure requirements using a fair value-based method of accounting for stock-based employee compensation plans, as amended by SFAS No. 148, “Accounting for Stock Based Compensation – Transition and Disclosure – an Amendment to SFAS 123.” As allowed by SFAS No. 123, we have elected to continue to apply the intrinsic value-based method of accounting described above, and have adopted the disclosure requirements of SFAS No. 123, as amended by SFAS No. 148. Had compensation cost for our stock-based compensation plans been determined based on the fair value at the grant dates for awards under those plans consistent with the method of SFAS No. 123, our pro-forma net loss and pro-forma net loss per share would have been as follows:

 

     (In thousands, except
per share data)


 
    

Three Months Ended
March 31,


 
     2004

    2003

 

Net loss:

                

As reported

   $ (79 )   $ (558 )

SFAS No. 123 Pro-forma

     (237 )     (825 )

Basic net loss per share

                

As reported

   $ (0.01 )   $ (0.07 )

SFAS No. 123 Pro-forma

     (0.03 )     (0.10 )

Diluted net loss per share:

                

As reported

   $ (0.01 )   $ (0.07 )

SFAS No. 123 Pro-forma

     (0.03 )     (0.10 )

 

We estimate the fair value of each option grant on the date of grant using the Black-Scholes option-pricing model with the following assumptions used for grants in the first quarter of 2004 and 2003, respectively; no estimated dividends; expected volatility of 119% for 2004 and 121% for 2003 risk-free interest rates between 2.79% and 3.12% in 2004 and between 2.78% and 3.05% in 2003 and expected option terms of five years for both years.

 

5


Table of Contents

4. Contingencies

 

We are, from time to time, subject to certain claims, assertions or litigation by outside parties as part of our ongoing business operations. The outcome of any such contingencies are not expected to have a material adverse effect upon our business, results of operations and financial condition. We are currently not a party to any material legal proceedings.

 

6


Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

This management’s discussion and analysis of financial condition and results of operations includes a number of forward-looking statements which reflect our current views with respect to future events and financial performance. These forward-looking statements are subject to certain risks and uncertainties, including those discussed below and those under the caption “Business Risks of Optika”, that could cause actual results to differ materially from historical results or those anticipated.

 

Overview

 

Optika® Inc. is a leading provider of enterprise content management (ECM) technology, including document imaging, workflow, collaboration and records management software. Our Acorde family of ECM software solutions, including Acorde Context(TM), Acorde Process(TM), Acorde Resolve(TM), Acorde Application Link(TM) and Acorde Records Management(TM), allows companies to streamline their business processes, eliminate paper, increase operational efficiencies and effectively leverage their enterprise resource planning (ERP) and line-of-business (LOB) systems. Acorde provides the ability to manage compliance requirements, access and store multiple formats of business content, both digital and non-digital; automate processes across the organization and externally with partners and customers; and enable online collaboration around these paper-intensive or complex processes in real and near time. Acorde supports a wide spectrum of critical business operations, including accounts payable, accounts receivable, claims processing, expense reporting, records management and human resources.

 

Built on a three-tier, scalable and extensible platform, Acorde easily integrates and interfaces with third-party applications. Acorde is certified with PeopleSoft, J.D. Edwards and Microsoft Business Solutions, and has performed integrations with many other major ERP and LOB systems, including Oracle, SAP, JDA and Lawson. The Acorde product family makes extensive use of Web Services to ensure seamless movement of transaction data and documents between application and across the enterprise. The Acorde product allows organizations to improve processing efficiency, reduce operating costs and increase customer, partner, and employee service and satisfaction, resulting in a significant return on investment.

 

The license of our software products is typically an executive-level decision by prospective end-users and generally requires our sales staff and/or our Advantage Partners (APs) to engage in a lengthy and complex sales cycle (typically between six and twelve months from the initial contact date). We distribute our products through a direct sales force and a network of APs. For 2003, approximately 47% of our license revenues were derived from our APs and the remaining license fees were derived from direct sales. However, no individual customer or AP accounted for more than 10% of our total revenues. For the years ended December 31, 2003, 2002 and 2001, we generated approximately 10%, 9% and 12%, respectively, of our total revenues from international sales. Our revenues consist primarily of license revenues, which are comprised of one-time fees for the license of our products, service revenues, and maintenance revenues, which are comprised of fees for upgrades and technical support. Our APs, which are responsible for the installation and integration of the software for their customers, enter into sales agreements with the end-user, and license software directly from us. We license software directly to the end-user through software license agreements. Annual maintenance agreements are also entered into between the APs and the end-user, and the APs then purchase maintenance services directly from us. For 2003, 2002 and 2001, approximately 34%, 32% and 38%, respectively, of our total revenues were derived from software licenses and approximately 47%, 43% and 43%, respectively, of our total revenues were derived from maintenance agreements. For 2003, 2002 and 2001, other revenues, which are comprised of training, consulting and implementation services, and third-party hardware and software products, accounted for 19%, 25% and 19%, respectively, of our total revenues.

 

Critical Accounting Policies

 

Our significant accounting policies are described in Note 1 in the Notes to Consolidated Financial Statements included in our Annual Report on Form 10-K for the year ended December 31, 2003, as amended. The accounting

 

7


Table of Contents

policies used in preparing our interim consolidated financial statements for the three months ended March 31, 2004 are the same as those described in our Annual Report on Form 10-K,